These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38244078)

  • 1. Specific association between retinal neural layer thinning and neurological soft signs in schizophrenia.
    Krukow P; Domagała A; Silverstein SM
    Eur Arch Psychiatry Clin Neurosci; 2024 Aug; 274(5):1237-1240. PubMed ID: 38244078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Layer Abnormalities as Biomarkers of Schizophrenia.
    Samani NN; Proudlock FA; Siram V; Suraweera C; Hutchinson C; Nelson CP; Al-Uzri M; Gottlob I
    Schizophr Bull; 2018 Jun; 44(4):876-885. PubMed ID: 29272501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography indices of structural retinal pathology in schizophrenia.
    Silverstein SM; Paterno D; Cherneski L; Green S
    Psychol Med; 2018 Sep; 48(12):2023-2033. PubMed ID: 29233210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder.
    Lizano P; Bannai D; Lutz O; Kim LA; Miller J; Keshavan M
    Schizophr Bull; 2020 Jan; 46(1):43-53. PubMed ID: 31112601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple retinal anomalies in schizophrenia.
    Adams SA; Nasrallah HA
    Schizophr Res; 2018 May; 195():3-12. PubMed ID: 28755877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal layers and symptoms and inflammation in schizophrenia.
    Carriello MA; Costa DFB; Alvim PHP; Pestana MC; Bicudo DDS; Gomes EMP; Coelho TA; Biava PJ; Berlitz VG; Bianchini AJ; Shiokawa A; Shiokawa N; Sato MT; Massuda R
    Eur Arch Psychiatry Clin Neurosci; 2024 Aug; 274(5):1115-1124. PubMed ID: 36928482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Soft Signs and Brain Network Abnormalities in Schizophrenia.
    Kong L; Herold CJ; Cheung EFC; Chan RCK; Schröder J
    Schizophr Bull; 2020 Apr; 46(3):562-571. PubMed ID: 31773162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography.
    Komatsu H; Onoguchi G; Silverstein SM; Jerotic S; Sakuma A; Kanahara N; Kakuto Y; Ono T; Yabana T; Nakazawa T; Tomita H
    Mol Psychiatry; 2024 Feb; 29(2):464-482. PubMed ID: 38081943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: Findings from spectral optic coherence tomography.
    Celik M; Kalenderoglu A; Sevgi Karadag A; Bekir Egilmez O; Han-Almis B; Şimşek A
    Eur Psychiatry; 2016 Feb; 32():9-15. PubMed ID: 26800301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinal investigations in patients with major depressive disorder, bipolar disorder or schizophrenia: A review of the literature].
    Tan A; Schwitzer T; Conart JB; Angioi-Duprez K
    J Fr Ophtalmol; 2020 Sep; 43(7):586-597. PubMed ID: 32631695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological Soft Signs Are Associated With Altered White Matter in Patients With Schizophrenia.
    Viher PV; Stegmayer K; Bracht T; Federspiel A; Bohlhalter S; Strik W; Wiest R; Walther S
    Schizophr Bull; 2022 Jan; 48(1):220-230. PubMed ID: 34355246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography.
    Lee WW; Tajunisah I; Sharmilla K; Peyman M; Subrayan V
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7785-92. PubMed ID: 24135757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders.
    Blose BA; Lai A; Crosta C; Thompson JL; Silverstein SM
    Schizophr Bull; 2023 Sep; 49(5):1316-1324. PubMed ID: 37459382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography.
    Chu EM; Kolappan M; Barnes TR; Joyce EM; Ron MA
    Psychiatry Res; 2012 Jul; 203(1):89-94. PubMed ID: 22917503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between retinal thickness and disease characteristics in adult epilepsy: A cross-sectional OCT evaluation.
    Delazer L; Bao H; Lauseker M; Stauner L; Nübling G; Conrad J; Noachtar S; Havla J; Kaufmann E
    Epilepsia Open; 2024 Feb; 9(1):236-249. PubMed ID: 37920967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological soft signs in early stage of schizophrenia associated with obsessive-compulsive disorder.
    Focseneanu BE; Dobrescu I; Marian G; Rusanu V
    J Med Life; 2015; 8 Spec Issue(Spec Issue):74-81. PubMed ID: 26361516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
    Chen Y; Colville D; Ierino F; Symons A; Savige J
    Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
    Saidha S; Syc SB; Ibrahim MA; Eckstein C; Warner CV; Farrell SK; Oakley JD; Durbin MK; Meyer SA; Balcer LJ; Frohman EM; Rosenzweig JM; Newsome SD; Ratchford JN; Nguyen QD; Calabresi PA
    Brain; 2011 Feb; 134(Pt 2):518-33. PubMed ID: 21252110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.